Pharmacologic Treatment Strategies in Psoriatic Arthritis

Ayan, G.; Ribeiro, A.; Macit, Betül; Proft, Fabian

doi:10.1016/j.clinthera.2023.05.010

Record: found
Abstract: not found
Article: not found

Pharmacologic Treatment Strategies in Psoriatic Arthritis

Author(s): G. Ayan , A. Ribeiro , Betul Macit , Fabian Proft

Publication date Created: July 2023

Publication date (Print): July 2023

Journal: Clinical Therapeutics

Publisher: Elsevier BV

Read this article at

ScienceOpenPublisher PubMed

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Most cited references 159

Record: found
Abstract: not found
Article: not found

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

J R Vane (1971)

0 comments Cited 645 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

William J Sandborn, Chinyu Su, Bruce Sands … (2017)

Tofacitinib, an oral, small-molecule Janus kinase inhibitor, was shown to have potential efficacy as induction therapy for ulcerative colitis in a phase 2 trial. We further evaluated the efficacy of tofacitinib as induction and maintenance therapy.

0 comments Cited 529 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

Brian Feagan, William J Sandborn, Christopher R Gasink … (2017)

Ustekinumab, a monoclonal antibody to the p40 subunit of interleukin-12 and interleukin-23, was evaluated as an intravenous induction therapy in two populations with moderately to severely active Crohn's disease. Ustekinumab was also evaluated as subcutaneous maintenance therapy.